Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zajecka

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|March 14, 2002
Six-year perspectives on the safety and tolerability of nefazodoneDavid L Dunner, Lyle K Laird, John Zajecka, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorderMaurizio Fava, Jonathan Alpert, Andrew A Nierenberg, et al.
International Clinical Psychopharmacology|April 19, 2003
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorderAnita H Clayton, John Zajecka, James M Ferguson, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 6, 2022
Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat DepressionChristoph Kraus, Darin Quach, David M Sholtes, et al.
JAMA Psychiatry|April 21, 2016
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164Steven D Hollon, Robert J DeRubeis, Jan Fawcett, et al.
JAMA Psychiatry|August 22, 2014
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trialSteven D Hollon, Robert J DeRubeis, Jan Fawcett, et al.
The International Journal of Neuropsychopharmacology|October 2, 2004
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placeboHarald Murck, Maurizio Fava, Jonathan Alpert, et al.
JAMA Psychiatry|December 5, 2019
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical TrialRobert J DeRubeis, John Zajecka, Richard C Shelton, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Journal of Psychiatric Research|July 6, 2010
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depressionCharles DeBattista, Gustavo Kinrys, Daniel Hoffman, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|March 14, 2002
Six-year perspectives on the safety and tolerability of nefazodoneDavid L Dunner, Lyle K Laird, John Zajecka, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorderMaurizio Fava, Jonathan Alpert, Andrew A Nierenberg, et al.
International Clinical Psychopharmacology|April 19, 2003
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorderAnita H Clayton, John Zajecka, James M Ferguson, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 6, 2022
Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat DepressionChristoph Kraus, Darin Quach, David M Sholtes, et al.
JAMA Psychiatry|April 21, 2016
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164Steven D Hollon, Robert J DeRubeis, Jan Fawcett, et al.
JAMA Psychiatry|August 22, 2014
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trialSteven D Hollon, Robert J DeRubeis, Jan Fawcett, et al.
The International Journal of Neuropsychopharmacology|October 2, 2004
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placeboHarald Murck, Maurizio Fava, Jonathan Alpert, et al.
JAMA Psychiatry|December 5, 2019
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical TrialRobert J DeRubeis, John Zajecka, Richard C Shelton, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Journal of Psychiatric Research|July 6, 2010
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depressionCharles DeBattista, Gustavo Kinrys, Daniel Hoffman, et al.
Pageof 4